Applications of Systems Engineering to Challenges of Therapeutic Protein Production

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Applications of Systems Engineering to Challenges of Therapeutic Protein Production

Alternative title

Published Date

2021-09

Publisher

Type

Thesis or Dissertation

Abstract

Mammalian cells are inherently complex, possessing unknown levels and details of regulation that dictate their behaviors in the context of their ever-changing environments. Despite that, Chinese Hamster Ovary (CHO) cells are a workhorse of the pharmaceutical industry; their products – therapeutic proteins –generate > $40 billion per annum. Cell metabolism drives cell growth and other behaviors. In establishing an industrial process for biologic generation with established cell lines, culture conditions are used to control cell growth, productivity, and product quality, including protein glycosylation. I have taken systems engineering approaches to increase our understanding and control of complex, but important, cellular metabolic behavior. To create new cell lines that produce desired glycoforms for protein therapeutics, the metabolic reactions supporting this critical quality attribute were systematically perturbed. An antibody producing cell line was characterized and found to produce IgG with low galactosylation. A library of genes intended to adjust enzyme kinetics and substrate availability within glycosylation was synthesized and the genes stably introduced to the cells. At the culmination of an iterative design strategy, three-gene cassettes containing galactosyltransferase, UDP-sugar transporters, and UDP-Galactose synthesis genes were found to substantially increase galactosylation on the final product. Dihydrofolate reductase (DHFR) and glutamine synthesis (GS) systems are the two major methods used to generate recombinant protein producing CHO cell lines. The DHFR selection system relies on the intervention of the folate synthesis pathway, while the GS system perturbs the supply of an essential amino acid. Cell lines created with the two methods differ metabolically while exhibiting general similarities. I have taken a system engineering approach, building data processing, aggregation, and analysis pipelines to facilitate big data compilation and process characterization. Comprehensive measurements using metabolomic and transcriptomic tools were employed, expanding beyond traditional analytes like glucose, lactate, and ammonia, and into extracellular and intracellular amino acids, metabolic by-products, trace metals, vitamins, and N-glycan composition of the product protein. Additionally, mRNA transcript levels at different metabolic states were obtained by RNAseq, while flux distribution in key metabolic nodes during key metabolic cell-states were evaluated by stoichiometric MFA. The comprehensive data set enabled the computation of intracellular metabolic flux distribution and further facilitated the adoption of a generic metabolic model for the cells. The metabolic model obtained can be extended to a process model for in silico process optimization and process performance prediction in scaling up and scaling down, presenting a systems approach demonstrated in this study that should be generally applicable to cell lines used in the production of biologics. By increasing our understanding of complex biological systems, we get closer to the goal of controlling desired metabolic behaviors in cells used for therapeutic protein production. A challenge towards this goal can be gathering and analyzing process data in a meaningful way. This work presents frameworks for methodically increasing our ability to obtain desired glucose and glycan metabolic phenotypes in industrially relevant CHO cell culture processes through integrated experimental and modeling frameworks.

Keywords

Description

University of Minnesota Ph.D. dissertation. September 2021. Major: Chemical Engineering. Advisor: Wei-Shou Hu. 1 computer file (PDF); xviii, 204 pages.

Related to

Replaces

License

Collections

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

McCann, Meghan. (2021). Applications of Systems Engineering to Challenges of Therapeutic Protein Production. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/225106.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.